awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27302763-62DB7752-3606-426C-A507-572E00701BEB
Q27302763-62DB7752-3606-426C-A507-572E00701BEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27302763-62DB7752-3606-426C-A507-572E00701BEB
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An
P921
Q27302763-62DB7752-3606-426C-A507-572E00701BEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27302763-62DB7752-3606-426C-A507-572E00701BEB
rank
NormalRank
type
BestRank
Statement
P921
patient